Business Wire

ZS Announces ZAIDYNTM Platform to Accelerate Digital Journeys in Life Sciences

14.9.2021 16:47:00 EEST | Business Wire | Press release

Share

Global professional services firm ZS has announced the launch of ZAIDYN by ZS—a platform for life sciences companies of all sizes to digitally transform and scale customer engagement, field performance, analytics and clinical capabilities.

ZAIDYN delivers through intelligent business applications, the power of a self-learning network and a ready-to-use library of algorithms. The platform integrates with existing technology environments via an open, modular, cloud-based architecture featuring business-ready connectors to third-party data sources, business apps and enterprise systems.

“Today, we are announcing ZAIDYN, expanding on more than 35 years of software expertise from our JAVELIN, VERSO and REVO product lines,” said Sanjay Joshi, managing principal and platform lead for ZS. “Built on a common foundation, ZAIDYN allows clients to adopt products, applications, algorithms and data assets in a modular way. It connects well with IT systems, resulting in easier integration, lower cost of operations and global scale. As a life sciences AI platform, ZAIDYN gets smarter over time and increases in value for our clients.”

With ZAIDYN, leaders in business, analytics and technology have more paths to improve the processes that deliver business and patient value. They can:

  • Drive faster and better decision-making with more insightful, dynamic reporting and analytics
  • Create personalized experiences to deepen customer relationships
  • Deploy and guide field teams for more effective support of healthcare markets
  • Spark digital learning for greater speed to value in business model transformation efforts
  • Ready company infrastructure for the future of digital clinical trial design and monitoring

More than 130 companies already use ZS’s products to drive business decisions, and over 100,000 pharmaceutical field reps worldwide use ZS insights to engage their customers.

“ZAIDYN will help our clients navigate the large-scale, disruptive changes we see happening across our industry,” said Pratap Khedkar, CEO of ZS. “Digital platforms for life sciences can help us deliver the experiences customers expect and businesses want. It’s all about using insights from data more effectively to drive better patient outcomes.”

“We’re changing how we support our commercial businesses with the help of ZS and the ZAIDYN platform,” said Andreas Henrich, corporate vice president of IT enterprise data services at Boehringer Ingelheim. “First, we updated and shifted our data and analytics solutions to a global cloud-based solution. Then, we plugged in the customer engagement capabilities we wanted on top. The platform integrates with our existing systems and can handle a lot more down the road as we deliver new customer and patient experiences.”

Learn more and register for upcoming webinars at zs.com/zaidyn.

About ZS

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 37 years of experience and 10,000-plus ZSers in more than 28 offices worldwide, we are passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Quintin Maidment
The Bliss Group
zs@theblissgrp.com
+1 212 600 2584

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 03:00:00 EEST | Press release

Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera

Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 02:00:00 EEST | Press release

Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Kath Harrison, Group President, International Growth at Real Chemistry. “By bringing Spurwing into Real Chemistry,

Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a

Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 21:30:00 EEST | Press release

The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stage name of Simone Privitera, an Italian multi-platinum DJ and producer who integrates artificial intelligence tools into a musical practice rooted in the contemporary electronic scene. With a career that has seen him collaborate wit

Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 16:00:00 EEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye